AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
4.960
+0.210 (4.42%)
At close: Mar 9, 2026, 4:00 PM EDT
4.640
-0.320 (-6.45%)
After-hours: Mar 9, 2026, 5:32 PM EDT
AVITA Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 10.24 | 14.05 | 22.12 | 18.16 | 55.51 | Upgrade
|
| Short-Term Investments | 7.94 | 21.84 | 66.94 | 61.18 | 29.65 | Upgrade
|
| Cash & Short-Term Investments | 18.19 | 35.89 | 89.06 | 79.34 | 85.16 | Upgrade
|
| Cash Growth | -49.32% | -59.71% | 12.24% | -6.83% | -23.10% | Upgrade
|
| Accounts Receivable | 9.09 | 11.79 | 7.69 | 3.53 | 3.43 | Upgrade
|
| Other Receivables | 0.02 | 0.12 | 0.23 | 1.18 | 0.09 | Upgrade
|
| Receivables | 9.11 | 11.91 | 7.92 | 4.71 | 3.51 | Upgrade
|
| Inventory | 6.93 | 7.27 | 5.6 | 2.13 | 2.13 | Upgrade
|
| Prepaid Expenses | 1.27 | 1.94 | 1.43 | 0.92 | 1.12 | Upgrade
|
| Restricted Cash | - | - | - | - | 0.2 | Upgrade
|
| Other Current Assets | - | - | - | 0.36 | 0 | Upgrade
|
| Total Current Assets | 35.49 | 57 | 104.01 | 87.46 | 92.13 | Upgrade
|
| Property, Plant & Equipment | 11.53 | 13.59 | 4.32 | 2.05 | 2.81 | Upgrade
|
| Long-Term Investments | - | - | - | 6.93 | 19.69 | Upgrade
|
| Other Intangible Assets | 5.65 | 5.57 | 0.49 | 0.47 | 0.44 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | 0.5 | Upgrade
|
| Other Long-Term Assets | 3.73 | 3.55 | 2.83 | 1.36 | 0.44 | Upgrade
|
| Total Assets | 56.39 | 79.71 | 111.64 | 98.26 | 116.02 | Upgrade
|
| Accounts Payable | 8.96 | 6.29 | 3.79 | 3 | 2.71 | Upgrade
|
| Accrued Expenses | 8.09 | 12.55 | 8.14 | 6.7 | 5.36 | Upgrade
|
| Current Portion of Long-Term Debt | 42.98 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.93 | 0.9 | 0.9 | 0.61 | 0.72 | Upgrade
|
| Current Unearned Revenue | 0.03 | 0.03 | 0.03 | - | - | Upgrade
|
| Other Current Liabilities | 1.68 | 0.39 | 0.34 | 0.38 | 0.36 | Upgrade
|
| Total Current Liabilities | 62.68 | 20.16 | 13.2 | 10.69 | 9.15 | Upgrade
|
| Long-Term Debt | - | 42.25 | 39.81 | - | - | Upgrade
|
| Long-Term Leases | 2.14 | 2.84 | 1.7 | 0.31 | 0.92 | Upgrade
|
| Long-Term Unearned Revenue | 0.29 | 0.32 | 0.36 | 0.7 | 0.95 | Upgrade
|
| Other Long-Term Liabilities | 7.94 | 9.65 | 7.51 | 1.83 | 0.38 | Upgrade
|
| Total Liabilities | 73.04 | 75.21 | 62.58 | 13.52 | 11.39 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 394.41 | 367.57 | 350.04 | 339.83 | 332.48 | Upgrade
|
| Retained Earnings | -408.4 | -359.81 | -297.97 | -262.59 | -235.92 | Upgrade
|
| Comprehensive Income & Other | -2.66 | -3.26 | -3.02 | 7.5 | 8.06 | Upgrade
|
| Shareholders' Equity | -16.65 | 4.5 | 49.06 | 84.74 | 104.62 | Upgrade
|
| Total Liabilities & Equity | 56.39 | 79.71 | 111.64 | 98.26 | 116.02 | Upgrade
|
| Total Debt | 46.05 | 45.99 | 42.41 | 0.92 | 1.64 | Upgrade
|
| Net Cash (Debt) | -27.86 | -10.1 | 46.65 | 85.35 | 103.21 | Upgrade
|
| Net Cash Growth | - | - | -45.35% | -17.30% | -5.45% | Upgrade
|
| Net Cash Per Share | -1.00 | -0.39 | 1.84 | 3.41 | 4.24 | Upgrade
|
| Filing Date Shares Outstanding | 30.63 | 26.36 | 25.71 | 25.3 | 24.93 | Upgrade
|
| Total Common Shares Outstanding | 30.57 | 26.35 | 25.68 | 25.21 | 24.93 | Upgrade
|
| Working Capital | -27.19 | 36.84 | 90.81 | 76.77 | 82.99 | Upgrade
|
| Book Value Per Share | -0.54 | 0.17 | 1.91 | 3.36 | 4.20 | Upgrade
|
| Tangible Book Value | -22.3 | -1.07 | 48.57 | 84.28 | 104.18 | Upgrade
|
| Tangible Book Value Per Share | -0.73 | -0.04 | 1.89 | 3.34 | 4.18 | Upgrade
|
| Machinery | 6.28 | 6.2 | 3.02 | 1.97 | 1.88 | Upgrade
|
| Construction In Progress | 0.02 | 0.44 | 0.09 | 0.26 | 0.03 | Upgrade
|
| Leasehold Improvements | 4.88 | 4.61 | 0.37 | 0.26 | 0.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.